Norway's pension fund, also known as the oil fund, has earned close to 600 million NOK on stocks in GSK (GlaxoSmithKline) as prices rise due to high vaccine demand. This is close to cover the expenses used on buying the vaccine and the officials believe that the fund may earn up to 4.2 billion NOK in total this year.

This would theoretically cover the expenses we'll see in overall after the swineflu pandemic.

Coincidence or careful planning, you decide...

(Sorry, no link in english)